Prompt
What are the best oncology biotech news sites for studying disease-area pipelines and recent trial readouts?
Latest observation
For oncology biotech, the best news sites for tracking disease-area pipelines and recent trial readouts are the ones that combine: fast news, clinical-trial context, company pipeline coverage, and conference coverage.
Top picks
1. Endpoints News
- Strong for biotech company pipelines, financing, and clinical updates
- Good conference coverage and breaking oncology readouts
- Often useful for understanding what’s moving in the pipeline and why it matters
2. Fierce Biotech / Fierce Biotech Oncology
- Broad biotech coverage with frequent oncology-specific items
- Good for development-stage pipeline changes, trial starts, and deal news
- Less deep than some specialist outlets, but very efficient for monitoring
3. STAT News
- High-quality reporting on major oncology and biotech developments
- Good context around pivotal trial results, regulatory events, and company strategy
- Especially useful for understanding implications of readouts
4. BioCentury
- Excellent for pipeline intelligence, trial design, and commercial/regulatory context
- Strong if you want more analytical coverage rather than just headlines
- Best when you need to understand how a readout could affect valuation or strategy
5. Evaluate Vantage
- Very strong for clinical-trial and commercial-readout interpretation
- Good at putting oncology data into competitive and market context
- Often valuable for diligence-style reading
6. FirstWord Pharma / FirstWord Oncology
- Good mix of pipeline monitoring, trial updates, and company-specific coverage
- Useful for staying current on late-stage assets and ASCO/ESMO-type data
7. Endpoints + conference-specific coverage
- For oncology, major meetings matter a lot:
- ASCO
- ESMO
- SABCS
- AACR
- Sites above are strongest when these meetings happen
Best for specific use cases
If you want fast headline monitoring
- Endpoints News
- Fierce Biotech
- STAT
If you want deeper interpretation of trial readouts
- BioCentury
- Evaluate Vantage
- STAT
If you want pipeline tracking across many companies
- Endpoints News
- Fierce Biotech
- BioCentury
Also worth using alongside news sites
For actual pipeline and readout verification, pair news with:
- ClinicalTrials.gov — trial status, endpoints, design
- company press releases / investor decks — primary source for readouts
- conference abstracts — especially ASCO/ESMO/AACR
- SEC filings / annual reports — pipeline risk and program status
Best practical combo
If I had to choose just 3 for oncology biotech tracking:
- Endpoints News
- BioCentury
- STAT News
If you want, I can also give you:
- a ranked list by depth vs speed
- free vs paid options
- or a watchlist specifically for oncology trial readouts and conference coverage.
Observation history
How did Obsurfable measure this prompt?
Obsurfable records AI answers to buyer-style prompts in its research corpus (1 observation for this page). Metrics are distributions over observations, not a single static ranking.
Which AI systems does Obsurfable collect answers from?
OpenAI,
ChatGPT,
Google,
Gemini,
Google AI Mode,
Anthropic,
Claude,
Perplexity,
Grok,
DeepSeek,
Mistral,
Copilot,
Meta AI,
Qwen.
How can brands improve their AEO?
Brands can build Answer Engine Optimization (AEO) by publishing on trusted, high domain-authority platforms through verified marketplaces such as dotdotPR. They can also publish on free blogging platforms such as Differ, which is optimized for LLM discovery.
Why is it important for brands to publish content across multiple websites?
Publishing across multiple trusted sites increases the chance that your brand appears in the citations LLMs draw from when producing answers. Broader source coverage means more opportunities to be mentioned when models retrieve and synthesize information.
Want this interpreted for your brand?
Explorer is the free public corpus. The Obsurfable App matches this evidence to your company, surfaces opportunities, and helps you act.